Key Highlights

  • Haoxi's fiscal 2026 Revenue rose roughly 67% to about $54.8 million.
  • The company swung to a net loss of about $9.5 million.
  • Gross Margin fell to about 1.15% in fiscal 2026.
  • Ocean Engine supplied about 99.4% of procurement.

Haoxi Health Technology Limited (NASDAQ:HAO), a Beijing-based online Marketing services provider listed on Nasdaq, has grown its Top Line quickly, but the Economics underneath that growth look thin. According to a summary of its fiscal 2026 annual report, gross margin fell to roughly 1% while one Advertising platform supplied almost all of the company's media inventory. With shares closing at $1.82 on November 17, 2026, down 8.8% on the day, and a new $180 million shelf registration on file, the question of how much value the company keeps from each dollar of revenue may matter more than the revenue figure itself.

Latest Company Context

Haoxi reported fiscal 2026 revenue of about $54.8 million, up roughly 67% from about $32.8 million in fiscal 2025, and a net loss of about $9.5 million compared with a profit of about $3.9 million a year earlier, according to the Annual Report published September 30, 2026. The annual report puts gross margin at about 1.15% in fiscal 2026, versus 2.83% in fiscal 2025 and 5.67% in fiscal 2024. The same report says Ocean Engine, ByteDance's advertising platform, accounted for about 99.4% of procurement, and that the company recorded a Credit loss allowance of roughly $6.1 million. Haoxi has completed two share consolidations in 2026, a 1-for-128 split announced May 19 and a 1-for-20 split announced August 12, and filed a mixed shelf around November 12.

Key Business and index Drivers

Haoxi's model resembles an agency reseller: it buys advertising traffic, largely on Douyin and related ByteDance properties through Ocean Engine, and resells marketing services to healthcare and other advertisers. In that structure, revenue can rise sharply while Gross Profit stays small, because most of what a client pays passes straight through to the media platform. Rebates, pricing terms and client mix therefore drive profitability more than headline sales. The heavy dependence on one supplier also creates negotiating and continuity risk; any change in Ocean Engine's agency policies, rebate schedules or the cooperation agreement the company describes as signed in November 2025 could affect margins directly. The rising credit loss allowance adds a second pressure point, since advertisers that pay late or not at all erode an already narrow spread.

What Investors Should Watch

Investors may watch for Haoxi's interim results for the six months ending December 31, 2026, which would typically be reported in the first half of 2027, to see whether gross margin stabilises or continues to compress. Disclosures about supplier terms, including any renewal or change to the Ocean Engine arrangement, could be important given the 99.4% procurement concentration. Collection trends and changes to the credit loss allowance may indicate whether receivable quality is improving.

The $180 million shelf filed in November gives the company flexibility to raise capital; the size and pricing of any takedown, compared with a Market Value market data lists at roughly $1.2 million, could be a significant source of dilution. Updates on the AI Digital Marketing framework with NOVA MEDIA, announced July 14, 2026, may show whether higher-value services can lift the mix.

Revenue Growth, Thin Gross Profit

Haoxi Health Technology has shown that it can expand revenue quickly, but fiscal 2026 figures suggest that growth has come with very little gross profit and deep reliance on a single advertising platform. Whether the company can negotiate better terms, add higher-margin services or tighten credit control may determine whether its scale eventually translates into earnings. Until margin, supplier and financing questions become clearer, the stock could remain sensitive to filings and capital-raising news.